Writing Multiple Marketing Applications Simultaneously With Accelerated Timelines

A mid-size pharmaceutical company and its development partner, a small biotechnology company engaged Veristat to complete the medical writing for their product’s Marketing Authorization Application (MAA), New Drug Application (NDA), and New Drug Submission (NDS).

Learn how our medical writing team worked closely with the sponsors to write these marketing applications in an accelerated timeline since the product received Orphan Drug Designation in the United States and Europe and Priority Review status in Canada.